Tscan Therapeutics Inc (TCRX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.6700 +0.0600 (+3.73%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.6700 unch (unch) 16:10 ET
for Fri, Mar 21st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 2,816 | 21,049 | 13,535 | 10,141 | 1,085 |
| Gross Profit | 2,816 | 21,049 | 13,535 | 10,141 | 1,085 |
| Operating Expenses | 137,637 | 114,507 | 80,171 | 58,782 | 27,318 |
| Operating Income | -134,821 | -93,458 | -66,636 | -48,641 | -26,233 |
| Interest Expense | 3,653 | 3,759 | 1,176 | 0 | 0 |
| Other Income | 10,975 | 7,999 | 1,591 | 16 | 106 |
| Pre-tax Income | -127,499 | -89,218 | -66,221 | -48,625 | -26,127 |
| Net Income Continuous | -127,499 | -89,218 | -66,221 | -48,625 | -26,127 |
| Net Income | $-127,499 | $-89,218 | $-66,221 | $-48,625 | $-26,127 |
| EPS Basic Total Ops | -1.14 | -1.36 | -2.75 | -4.17 | -28.52 |
| EPS Basic Continuous Ops | -1.14 | -1.36 | -2.75 | -4.17 | -28.52 |
| EPS Diluted Total Ops | -1.14 | -1.36 | -2.75 | -4.17 | -28.52 |
| EPS Diluted Continuous Ops | -1.14 | -1.36 | -2.75 | -4.17 | -28.52 |
| EPS Diluted Before Non-Recurring Items | -1.13 | -1.36 | -2.75 | -4.17 | N/A |
| EBITDA(a) | $-130,713 | $-88,097 | $-61,499 | $-45,313 | $-25,003 |